If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Francesco Grossi is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 68 Similar Profiles
Non-Small Cell Lung Carcinoma Medicine & Life Sciences
Drug Therapy Medicine & Life Sciences
Pemetrexed Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
docetaxel Medicine & Life Sciences
Survival Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
gemcitabine Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1996 2019

  • 4398 Citations
  • 34 h-Index
  • 180 Article
  • 14 Review article
  • 1 Editorial
  • 1 Letter

Baseline serum levels of osteopontin predict clinical response to treatment with nivolumab in patients with non-small cell lung cancer

Carbone, F., Grossi, F., Bonaventura, A., Vecchié, A., Minetti, S., Bardi, N., Elia, E., Ansaldo, A. M., Ferrara, D., Rijavec, E., Dal Bello, M. G., Biello, F., Rossi, G., Tagliamento, M., Alama, A., Coco, S., Spallarossa, P., Dallegri, F., Genova, C. & Montecucco, F., Oct 15 2019, In : Clinical and Experimental Metastasis. 36, 5, p. 449-456 8 p.

Research output: Contribution to journalArticle

Osteopontin
Non-Small Cell Lung Carcinoma
Serum
Therapeutics
C-Reactive Protein

Integrated somatic and germline whole-exome sequencing analysis inwomen with lung cancer after a previous breast cancer

Coco, S., Bonfiglio, S., Cittaro, D., Vanni, I., Mora, M., Genova, C., Bello, M. G. D., Boccardo, S., Alama, A., Rijavec, E., Sini, C., Rossella, V., Barletta, G., Biello, F., Truini, A., Bruzzo, C., Gallo, M., Lazarevic, D., Ballestrero, A. & Grossi, F., Apr 1 2019, In : Cancers. 11, 4, 441.

Research output: Contribution to journalArticle

Open Access
Exome
Lung Neoplasms
Breast Neoplasms
Smoking
Survivors

Italian Cohort of Nivolumab Expanded Access Program in Squamous Non-Small Cell Lung Cancer: Results from a Real-World Population

Crinò, L., Bidoli, P., Delmonte, A., Grossi, F., De Marinis, F., Ardizzoni, A., Vitiello, F., Lo Russo, G., Parra, H. S., Cortesi, E., Cappuzzo, F., Calabrò, L., Tiseo, M., Turci, D., Gamucci, T., Antonelli, P., Morabito, A., Chella, A., Giannarelli, D. & Galetta, D., Jan 1 2019, In : Oncologist.

Research output: Contribution to journalArticle

Non-Small Cell Lung Carcinoma
Population
Survival
Controlled Clinical Trials
docetaxel

Italian cohort of the nivolumab EAP in squamous NSCLC: Efficacy and safety in patients with CNS metastases

Cortinovis, D., Chiari, R., Catino, A., Grossi, F., Marinis, F. D. E., Sperandi, F., Piantedosi, F., Vitali, M., Soto Parra, H. J., Migliorino, M. R., Tondini, C., Tassinari, D., Frassoldati, A., Verderame, F., Pazzola, A., Cognetti, F., Palmiotti, G., Marchetti, P., Santoro, A., Giannarelli, D. & 2 others, Colonese, F. & Delmonte, A., Jan 1 2019, In : Anticancer Research. 39, 8, p. 4265-4271 7 p.

Research output: Contribution to journalArticle

Patient Safety
Non-Small Cell Lung Carcinoma
Central Nervous System
Neoplasm Metastasis
Confidence Intervals

Microtubule-targeting agents in the treatment of non-small cell lung cancer: insights on new combination strategies and investigational compounds

Tagliamento, M., Genova, C., Rossi, G., Coco, S., Rijavec, E., Dal Bello, M. G., Boccardo, S., Grossi, F. & Alama, A., Jun 3 2019, In : Expert Opinion on Investigational Drugs. 28, 6, p. 513-523 11 p.

Research output: Contribution to journalReview article

Open Access
Non-Small Cell Lung Carcinoma
Microtubules
Tubulin Modulators
Vinca Alkaloids
Drug Therapy